Central Nervous System Pharmacology Practice Questions

Q: How do benzodiazepines exert their sedative effects?

They enhance GABAergic transmission.. ***They enhance GABAergic transmission.*** - Benzodiazepines bind to a specific site on the **GABA-A receptor**, increasing its affinity for the **neurotransmitter GABA**. - This binding leads to an increased frequency of **chloride channel opening**, hyperpolarizing the neuron and making it less excitable, which produces sedative effects. *They increase norepinephrine levels and enhance GABA transmission.* - While benzodiazepines enhance GABA transmission, they do **not primarily increase norepinephrine levels**. - Medications that increase norepinephrine levels, such as certain antidepressants, typically have stimulating rather than sedative effects. *They block dopamine receptors and enhance GABA transmission.* - While benzodiazepines enhance GABA transmission, they do **not block dopamine receptors**. - Blocking dopamine receptors is the primary mechanism of action for many **antipsychotic medications**, which have different pharmacological profiles and side effects compared to benzodiazepines. *They inhibit acetylcholine release and enhance GABA transmission.* - While benzodiazepines enhance GABA transmission, they generally do **not directly inhibit acetylcholine release**. - Muscarinic acetylcholine receptor antagonists (anticholinergics) inhibit acetylcholine and can cause sedation, but this is a distinct mechanism from benzodiazepines.

Q: A patient with multiple sclerosis presents with worsening spasticity. Which of the following drugs would be most appropriate for managing spasticity in this patient?

Baclofen. ***Baclofen*** - **Baclofen** is a **GABA-B receptor agonist** that works by inhibiting excitatory neurotransmission in the spinal cord, effectively reducing **spasticity** in conditions like multiple sclerosis. - It is a first-line treatment for managing chronic severe spasticity due to its effectiveness in muscle relaxation and pain reduction. *Ibuprofen* - **Ibuprofen** is a **non-steroidal anti-inflammatory drug (NSAID)** primarily used for pain and inflammation, and it has no direct effect on muscle spasticity. - While it might alleviate some associated musculoskeletal pain, it does not address the underlying neurological cause of **spasticity**. *Diazepam* - **Diazepam** is a **benzodiazepine** that acts as a **GABA-A receptor positive allosteric modulator**, enhancing GABAergic inhibition and leading to generalized muscle relaxation and sedation. - While it can reduce spasticity, its use is often limited due to significant **sedation**, cognitive impairment, and potential for dependence, especially in long-term management, making it a second-line agent compared to baclofen. *Phenytoin* - **Phenytoin** is an **antiepileptic drug** primarily used to treat seizures and certain neuropathic pains. - It works by blocking voltage-gated sodium channels and has no significant role in the management of **spasticity** in multiple sclerosis.

Q: Which of the following is the most appropriate pharmacological treatment for neuropathic pain in a diabetic patient?

Gabapentin. ***Gabapentin*** - **Gabapentin** is a widely recommended first-line treatment for diabetic neuropathic pain due to its efficacy in modulating neuronal excitability. - It works by binding to the **α2δ subunit of voltage-gated calcium channels**, reducing calcium influx and thereby decreasing the release of excitatory neurotransmitters involved in pain signaling. *Acetaminophen* - **Acetaminophen** is primarily an analgesic and antipyretic, effective for mild to moderate non-neuropathic pain. - It has no significant efficacy against **neuropathic pain**, which involves distinct neurobiological mechanisms. *Tramadol* - **Tramadol** is an opioid analgesic with some serotonin and norepinephrine reuptake inhibition, offering moderate pain relief. - While it can be used for moderate to severe pain, it is generally considered a **second-line agent** for neuropathic pain due to its opioid nature and potential side effects. *Aspirin* - **Aspirin** is a nonsteroidal anti-inflammatory drug (NSAID) primarily used for its anti-inflammatory, analgesic, and antiplatelet effects. - It is **ineffective for neuropathic pain**, which does not typically involve peripheral inflammation as its primary mechanism.

Q: Which of the following drugs is most commonly used for the acute management of migraine?

Sumatriptan. ***Sumatriptan*** - **Triptans** such as sumatriptan are **serotonin 5-HT1B/1D receptor agonists** that cause **vasoconstriction** of intracranial blood vessels and inhibit neuropeptide release. - They are considered **first-line agents** for the acute management of moderate to severe migraine attacks. - Sumatriptan is the most commonly recommended and used triptan for acute migraine treatment. *Amitriptyline* - **Amitriptyline** is a **tricyclic antidepressant** primarily used for **migraine prophylaxis** (prevention), not acute treatment. - Its mechanism involves modulating neurotransmitter levels in the brain to reduce migraine frequency. *Ibuprofen* - **Ibuprofen** is a **non-steroidal anti-inflammatory drug (NSAID)** that can be used for **mild to moderate migraine** attacks. - While effective for milder cases, **triptans are superior** for moderate to severe migraines and are the **standard first-line choice** in acute migraine management guidelines. *Propranolol* - **Propranolol** is a **beta-blocker** primarily used for **migraine prophylaxis**, meaning it is taken regularly to prevent migraines. - It reduces the frequency and severity of migraine attacks but is not effective for stopping an acute attack once it has started.

Q: Which of the following is considered the MOST effective first-line pharmacotherapy for tobacco cessation in non-pregnant adults based on clinical trial evidence?

Varenicline. ***Varenicline*** - **Varenicline** has been shown in clinical trials to be the **most effective single agent** for tobacco cessation, significantly increasing abstinence rates compared to placebo and other pharmacotherapies. - Its mechanism involves **partial agonism of the α4β2 nicotinic acetylcholine receptor**, reducing cravings and withdrawal symptoms while blocking the dopamine reward pathway if nicotine is consumed. *Bupropion* - **Bupropion** is an antidepressant that also aids in smoking cessation by inhibiting the reuptake of **norepinephrine** and **dopamine**. - While effective, its efficacy in clinical trials is generally considered **lower than that of varenicline**. *Nicotine replacement therapy* - **Nicotine replacement therapy (NRT)** delivers nicotine without the harmful chemicals in tobacco, alleviating withdrawal symptoms and cravings. - Although effective and available in many forms (patches, gum, lozenges, inhalers, nasal sprays), **individual NRT products are less effective than varenicline** when used as monotherapy. *Clonidine* - **Clonidine** is an alpha-2 adrenergic agonist that can help reduce nicotine withdrawal symptoms like anxiety and restlessness. - However, its use is **limited by side effects** such as sedation and hypotension, and it is generally considered a **second-line or adjunctive treatment**, with lower efficacy than other first-line agents.

Q: Which drug is contraindicated in a patient with a history of porphyria?

Thiopental. ***Thiopental*** - **Thiopental** is a **barbiturate** known to induce **delta-aminolevulinic acid (ALA) synthase**, which is the rate-limiting enzyme in **heme synthesis**. - This enzyme induction can precipitate acute attacks in patients with **porphyria**, a group of genetic disorders affecting heme production. *Propofol* - **Propofol** is a widely used intravenous anesthetic that is generally considered **safe** in patients with porphyria. - It does not significantly stimulate **ALA synthase** activity or interfere with heme metabolism. *Midazolam* - **Midazolam** is a **benzodiazepine** used for sedation and anesthesia. Like propofol, it is generally considered **safe** in patients with porphyria. - Benzodiazepines do not typically induce **porphyrin synthesis**. *Etomidate* - **Etomidate** is an intravenous anesthetic that acts as a GABA-A receptor modulator. It is also generally considered **safe** for use in patients with porphyria. - While etomidate can sometimes have mild effects on steroid synthesis, it does not significantly impact the **heme biosynthesis pathway** in a way that would trigger porphyric attacks.

Q: Which drug class is commonly used as a first-line treatment for neuropathic pain?

Antiepileptics. ***Antiepileptics*** - Certain antiepileptics, particularly **gabapentin** and **pregabalin**, are considered **first-line agents** for neuropathic pain due to their ability to modulate **neurotransmitter release** in the central nervous system. - They work by binding to the **α2δ subunit of voltage-gated calcium channels**, reducing neuronal excitability. - These are often **preferred first-line** due to better tolerability compared to other first-line options. *Tricyclic antidepressants (TCAs)* - TCAs like **amitriptyline** and **nortriptyline** are also considered **first-line agents** for neuropathic pain by major guidelines. - However, they are often **less preferred** as initial therapy due to their significant **side effect profile**, such as **anticholinergic effects** and **cardiac toxicity**, especially in elderly patients. - Their mechanism involves **blocking the reuptake of norepinephrine and serotonin**, which modulates descending pain pathways. *Opioids (narcotics)* - **Opioids** are generally reserved for **severe neuropathic pain** that is refractory to first-line agents, due to concerns about **addiction**, **tolerance**, and a broad range of **side effects**. - They exert their analgesic effects by binding to **opioid receptors** in the central and peripheral nervous systems. *Corticosteroids (anti-inflammatory drugs)* - **Corticosteroids** are primarily used for **inflammatory pain** conditions and are generally **ineffective** for the direct treatment of neuropathic pain, which arises from nerve damage or dysfunction. - Their mechanism involves widespread **anti-inflammatory** and **immunosuppressive** effects.

Q: What is the first-line treatment for status epilepticus?

Lorazepam. ***Lorazepam*** - **Benzodiazepines** like lorazepam are the **first-line treatment** for status epilepticus due to their rapid onset of action and efficacy in terminating seizures. - Lorazepam is preferred over other benzodiazepines in IV form because of its **longer duration of action** and **lesser lipid solubility**, which keeps it in the central nervous system for longer. *Phenytoin* - **Phenytoin** is typically used as a **second-line agent** or as a maintenance therapy after the initial seizure has been controlled with a benzodiazepine. - It has a slower onset of action compared to benzodiazepines and is primarily used to prevent seizure recurrence. *Valproic acid* - **Valproic acid** is an **anti-epileptic drug** that can be used for status epilepticus, but it is not typically the first-line agent. - It is often considered in cases refractory to benzodiazepines or as an alternative in specific patient populations. *Diazepam* - While **diazepam** is a **benzodiazepine** used for status epilepticus, it has a **shorter duration of action** compared to lorazepam when administered intravenously. - Its rapid redistribution out of the CNS makes it less ideal for sustained seizure control compared to lorazepam in the initial management of status epilepticus.

Q: What is the drug of choice for the prophylactic treatment of migraine headaches?

Topiramate. ***Topiramate*** - **Topiramate** is a commonly prescribed and highly effective **antiepileptic drug** that is also approved for the prophylactic treatment of **migraine headaches**. - Its mechanism of action in migraine prevention involves **modulating neurotransmitter activity**, stabilizing neuronal excitability, and potentially reducing cortical spreading depression. *Sumatriptan* - **Sumatriptan** is a **triptan derivative** primarily used for the **acute treatment** of migraine attacks, not for prophylaxis. - It works by **constricting cranial blood vessels** and inhibiting the release of pro-inflammatory neuropeptides to abort an ongoing migraine. *Ibuprofen* - **Ibuprofen** is a **nonsteroidal anti-inflammatory drug (NSAID)** used for the **acute symptomatic relief** of mild to moderate headache pain, including some migraines. - It is not considered a primary drug for the **prophylactic prevention** of chronic migraine headaches. *Paracetamol* - **Paracetamol (acetaminophen)** is an **analgesic and antipyretic** used for general pain relief and fever, and can provide symptomatic relief for mild headaches. - Like ibuprofen, it does not have efficacy as a **prophylactic agent** for migraine prevention, nor is it recommended for this purpose.

Q: Which drug class is known for treating Parkinson's disease by inhibiting monoamine oxidase type B (MAO-B)?

MAO-B inhibitors. ***MAO-B inhibitors*** - This drug class, which includes **selegiline** and **rasagiline**, specifically targets and inhibits **monoamine oxidase type B (MAO-B)**. - By inhibiting MAO-B, these drugs reduce the breakdown of **dopamine** in the brain, thereby increasing its availability and alleviating Parkinson's symptoms. *Dopamine agonists* - These drugs, such as **pramipexole** and **ropinirole**, directly stimulate **dopamine receptors** in the brain. - While effective in treating Parkinson's, their mechanism of action is **receptor activation**, not enzyme inhibition. *COMT inhibitors* - These drugs, like **entacapone** and **tolcapone**, inhibit **catechol-O-methyltransferase (COMT)**, an enzyme that metabolizes dopamine. - They are used as adjunct therapy to **levodopa** to prolong its effects, but they do not inhibit MAO-B. *Anticholinergics* - This class of drugs, including **benztropine** and **trihexyphenidyl**, targets the **cholinergic system** by blocking acetylcholine receptors. - They are primarily used to manage **tremor** and **dystonia** in Parkinson's disease, but their action is not on dopamine metabolism via MAO-B.

Question 1

How do benzodiazepines exert their sedative effects?

Accepted Answer

They enhance GABAergic transmission.

Answer

They increase norepinephrine levels and enhance GABA transmission.

Answer

They block dopamine receptors and enhance GABA transmission.

Answer

They inhibit acetylcholine release and enhance GABA transmission.

Question 2

A patient with multiple sclerosis presents with worsening spasticity. Which of the following drugs would be most appropriate for managing spasticity in this patient?

Accepted Answer

Baclofen

Answer

Ibuprofen

Answer

Diazepam

Answer

Phenytoin

Question 3

Which of the following is the most appropriate pharmacological treatment for neuropathic pain in a diabetic patient?

Accepted Answer

Gabapentin

Answer

Acetaminophen

Answer

Tramadol

Answer

Aspirin

Question 4

Which of the following drugs is most commonly used for the acute management of migraine?

Accepted Answer

Sumatriptan

Answer

Amitriptyline

Answer

Ibuprofen

Answer

Propranolol

Question 5

Which of the following is considered the MOST effective first-line pharmacotherapy for tobacco cessation in non-pregnant adults based on clinical trial evidence?

Accepted Answer

Varenicline

Answer

Bupropion

Answer

Nicotine replacement therapy

Answer

Clonidine

Question 6

Which drug is contraindicated in a patient with a history of porphyria?

Accepted Answer

Thiopental

Answer

Propofol

Answer

Midazolam

Answer

Etomidate

Question 7

Which drug class is commonly used as a first-line treatment for neuropathic pain?

Accepted Answer

Antiepileptics

Answer

Tricyclic antidepressants (TCAs)

Answer

Opioids (narcotics)

Answer

Corticosteroids (anti-inflammatory drugs)

Question 8

What is the first-line treatment for status epilepticus?

Accepted Answer

Lorazepam

Answer

Phenytoin

Answer

Valproic acid

Answer

Diazepam

Question 9

What is the drug of choice for the prophylactic treatment of migraine headaches?

Accepted Answer

Topiramate

Answer

Sumatriptan

Answer

Ibuprofen

Answer

Paracetamol

Question 10

Which drug class is known for treating Parkinson's disease by inhibiting monoamine oxidase type B (MAO-B)?

Accepted Answer

MAO-B inhibitors

Answer

Dopamine agonists

Answer

COMT inhibitors

Answer

Anticholinergics

Central Nervous System Pharmacology — MCQs

Central Nervous System Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?